TruSpine Technologies PLC Director/PDMR Shareholding
March 21 2024 - 3:00AM
RNS Regulatory News
RNS Number : 6946H
TruSpine Technologies PLC
21 March 2024
21 March 2024
TruSpine Technologies
plc
("TruSpine" or the
"Company")
Director
Dealing
TruSpine Technologies Plc, the
medical device company focused on the spinal (vertebral)
stabilisation market, announces that it
received notification on 20 March 2024 that Geoff Miller, Chairman
of the Company, made the following purchase of ordinary shares in
the capital of the Company on 20 March 2024. Further details are
set out in the Notification of Dealing Form below.
|
Director
|
Purchase price (Aggregated)
|
Ordinary shares
purchased
|
Resultant interest in
ordinary shares
|
Resultant percentage of
issued ordinary shares
|
|
Geoff Miller
|
0.75
pence
|
500,000
|
10,111,828
|
7.24%
|
This announcement contains inside
information for the purposes of the UK Market Abuse Regulation and
the Directors of the Company are responsible for the release of
this announcement.
Enquiries:
|
TruSpine Technologies
Plc
|
Tel: +44 (0)20 7118 0852
|
|
Laurence Strauss, Chief Executive
Officer
|
|
|
|
|
|
Cairn Financial Advisers LLP
(AQSE Corporate Adviser)
|
Tel: +44
(0)20 7213 0880
|
|
Liam Murray / Ludovico
Lazzaretti
|
|
|
Peterhouse Capital Limited
(Broker & Financial Adviser)
|
Tel: +44 (0)20 7469 0930
|
|
Lucy Williams / Duncan
Vasey
|
|
|
Novus Communications (PR and
IR)
|
Tel: +44
(0)207 448 9839
|
|
Alan Green / Jacqueline
Briscoe
|
novuscomms@truspine.org
|
Caution regarding forward looking
statements
Certain statements in this
announcement, are, or may be deemed to be, forward looking
statements. Forward looking statements are identified by their use
of terms and phrases such as ''believe'', ''could'', "should"
''envisage'', ''estimate'', ''intend'', ''may'', ''plan'',
''potentially'', "expect", ''will'' or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements reflect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Geoffrey Richard Miller
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chairman
|
|
b.
|
Initial notification/
Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
TruSpine Technologies Plc
|
|
b.
|
LEI
|
213800HNZX9B1QZPB225
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of 0.01 pence
each
ISIN: GB00BMZCKL55
|
|
b.
|
Nature of the transaction
|
Purchase of ordinary
shares
|
|
c.
|
Price(s) and volume(s)
|
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
0.75 pence
|
500,000
|
|
|
|
|
d.
|
Aggregated information
- Volume
- Price
|
N/A
|
|
e.
|
Date of the transaction
|
20 March 2024
|
|
f.
|
Place of the transaction
|
Aquis Stock Exchange
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXDBGDXIUDDGSG
TruSpine Technologies (AQSE:TSP)
Historical Stock Chart
From Oct 2024 to Nov 2024
TruSpine Technologies (AQSE:TSP)
Historical Stock Chart
From Nov 2023 to Nov 2024
